[go: up one dir, main page]

EP0527771A4 - Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals - Google Patents

Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals

Info

Publication number
EP0527771A4
EP0527771A4 EP19910907676 EP91907676A EP0527771A4 EP 0527771 A4 EP0527771 A4 EP 0527771A4 EP 19910907676 EP19910907676 EP 19910907676 EP 91907676 A EP91907676 A EP 91907676A EP 0527771 A4 EP0527771 A4 EP 0527771A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
animals
treatment against
polypeptides useful
against mycoplasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910907676
Other versions
EP0527771A1 (en
Inventor
Jerry M. Kuner
Christine Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Boulder Inc
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of EP0527771A1 publication Critical patent/EP0527771A1/en
Publication of EP0527771A4 publication Critical patent/EP0527771A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19910907676 1990-04-02 1991-04-01 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals Withdrawn EP0527771A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50264090A 1990-04-02 1990-04-02
US502640 1990-04-02

Publications (2)

Publication Number Publication Date
EP0527771A1 EP0527771A1 (en) 1993-02-24
EP0527771A4 true EP0527771A4 (en) 1993-05-05

Family

ID=23998721

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910907676 Withdrawn EP0527771A4 (en) 1990-04-02 1991-04-01 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals

Country Status (7)

Country Link
EP (1) EP0527771A4 (en)
JP (1) JPH05506984A (en)
AU (2) AU7682091A (en)
CA (1) CA2078131A1 (en)
FI (1) FI924428A7 (en)
HU (1) HUT65827A (en)
WO (1) WO1991015593A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489430A (en) 1992-05-29 1996-02-06 Nippon Zeon Co., Ltd. Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
KR20010032493A (en) * 1997-11-26 2001-04-25 아이오와 스테이트 유니버시티 리서치 파운데이션, 인코퍼레이티드 Recombinant mycoplasma hyopneumoniae vaccine
CN1612749A (en) * 2001-07-02 2005-05-04 辉瑞产品公司 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
KR20040030785A (en) 2001-07-02 2004-04-09 화이자 프로덕츠 인크. One dose vaccination with mycoplasma hyopneumoniae

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000977A1 (en) * 1986-07-25 1988-02-11 Synergen, Inc. Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same
EP0283840A2 (en) * 1987-03-26 1988-09-28 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000977A1 (en) * 1986-07-25 1988-02-11 Synergen, Inc. Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same
EP0283840A2 (en) * 1987-03-26 1988-09-28 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9115593A1 *

Also Published As

Publication number Publication date
WO1991015593A1 (en) 1991-10-17
CA2078131A1 (en) 1991-10-03
AU1760295A (en) 1995-10-26
FI924428A0 (en) 1992-10-01
JPH05506984A (en) 1993-10-14
HUT65827A (en) 1994-07-28
FI924428L (en) 1992-10-01
HU9203128D0 (en) 1992-12-28
EP0527771A1 (en) 1993-02-24
FI924428A7 (en) 1992-10-01
AU7682091A (en) 1991-10-30

Similar Documents

Publication Publication Date Title
US5604105B1 (en) Method and device for diagnosingand distinguishing chest pain in early onset thereof
ZA917170B (en) Novel antibodies for treatment and prevention of infection in animals and man
OA09736A (en) "Human interleukin-3 and muteins thereof".
EP0481600A3 (en) Materials useful in human and veterinary medicine
EP0021230A3 (en) An agent for preventing or treating infections in human beings and animals
EP0472215A3 (en) Water-repellent and oil-repellent treatment agent
DK295190A (en) COSMETICS AND SKIN TREATMENT COMPOSITIONS
EP0557388A4 (en) Diagnosis and treatment of multiple sclerosis
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
EP0527771A4 (en) Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
GB9109556D0 (en) Personal perfume and/or deoderant device
NZ239183A (en) Peptides antagonistic against bombesin or like proteins and their use in the treatment of disease
EP0540575A4 (en) Human meg-csf protein and methods
GB9019413D0 (en) Topical treatment and composition
GB9013872D0 (en) Use of protein a and polypeptide components thereof in the treatment of tumours
GR900200303U (en) Face and body skin treatment
KR960006863B1 (en) Pharmaceutical preparation for treatment of mastitis in animals and humans
EP0452941A3 (en) Use of isomonools in the treatment and prophylaxis of cancer
GB9005323D0 (en) Beauty and skin care
IT217303Z2 (en) SIMPLIFIED DIAGNOSIS AND TREATMENT SHEET IN ODONTOSTOMATOLOGICAL PRACTICE
IL94396A0 (en) Methods and mechanisms of connection between tissues in the human body
EP0480843A3 (en) Antithrombogenic medical material and medical device
GB9419549D0 (en) Polypeptides and their use in the treatment of auto-immune disease
ES273112Y (en) "EVACUATOR DEVICE FOR SEGREGATIONS IN HUMAN AND ANIMAL BODY CAVITIES"
LV5177A3 (en) Preparation "eridone" for the prevention and treatment of endometritis in cows

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920930

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930315

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19950103

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19961121